No profile data available.
Satellos Bioscience Inc. (MSLE) is a listed company, based in Toronto, Canada, with about 18 full-time employees.
Its market capitalization was $158.91 million as of October 9, 2026.
Figures from company filings and market data; market data as of October 9, 2026.
, a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo.
$158.91 million as of October 9, 2026.